Tapinarof Cream 1% Once Daily for the Treatment of Plaque Psoriasis: Case Photography of Clinical Outcomes from Three Phase 3 Trials

Tapinarof cream 1% (VTAMA(®); Dermavant Sciences, Inc.) is a non-steroidal, topical, aryl hydrocarbon receptor agonist approved by the US Food and Drug Administration (FDA) to treat plaque psoriasis in adults and under investigation for the treatment of psoriasis in children down to 2 years of age,...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Seemal R., Stein Gold, Linda, Cameron, Michael C., Golant, Alexandra, Lewitt, G. Michael, Bruno, Matthew J., Martin, George, Brown, Philip M., Rubenstein, David S., Butners, Victoria, Tallman, Anna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539260/
https://www.ncbi.nlm.nih.gov/pubmed/37697121
http://dx.doi.org/10.1007/s13555-023-01008-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539260/
https://www.ncbi.nlm.nih.gov/pubmed/37697121
http://dx.doi.org/10.1007/s13555-023-01008-9

Ejemplares similares